The diet of industrialized nations may contribute to the pathogenesis of both ulcerative colitis (UC) and Crohn disease (CD). Malnutrition is relatively unusual in UC, but in CD, which often affects the small intestine, it is frequent and may be severe. Nutrition support is therefore frequently indicated. First principles of artificial nutrition can be applied effectively using the gut whenever possible. Parenteral nutrition is generally required only in those with short bowel syndrome. An increasing literature (especially in pediatrics) favors the use of defined exclusive enteral nutrition (EN) in the primary treatment of active CD. Controlled trials are, however, lacking, and recommendations are accordingly not of the highest rank. It appears that in this context, simple polymeric regimens are usually sufficient, and there is currently insufficient evidence to make a strong recommendation for disease-specific feeds. In the maintenance of remission in CD, controlled data demonstrate that defined EN reduces the risk of relapse requiring steroid treatment. There are no data in support of primary nutrition therapy in UC either in management of the acute flare or in maintenance. In conclusion, nutrition therapy in adults with inflammatory bowel disease is probably both undervalued and underused, but the evidence base needs to be strengthened to confirm its efficacy, determine better those patients most likely to benefit, and optimize the regimens to be employed.
GlassmanMSNewmanLJBerezinSGryboskiJD. Cow’s milk protein sensitivity during infancy in patients with inflammatory bowel disease. Am J Gastroenterol. 1990;85:838-840.
2.
KoletzkoSShermanPCoreyMGriffithsASmithC. Role of infant feeding practices in development of Crohn’s disease in childhood. Br Med J. 1989;298:1617-1618.
AmreDKD’SouzaSMorganK. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn’s disease in children. Am J Gastroenterol. 2007;102(9):2016-2025.
5.
TjonnelandAOvervadKBergmannMM. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis. Gut. 2009;58:1606-1611.
6.
HodgesPGeeMGraceMSherbaniukRWWenselRHThomsonAB. Protein-energy intake and malnutrition in Crohn’s disease. J Am Diet Assoc. 1984;84:1460-1464.
van HogezandRAHamdyNA. Skeletal morbidity in inflammatory bowel disease [review]. Scand J Gastroenterol Suppl. 2006;(243): 59-64.
9.
ThayuMLeonardMBHyamsJS; Reach Study Group. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn’s disease: results of the REACH study. Clin Gastroenterol Hepatol. 2008;6(12):1378-1384.
10.
ShibukawaNNezuRMurataM. Two cases of treatment with infliximab which replaced long-term home parenteral nutrition and maintained remission in patients with Crohn disease. Nippon Shokakibyo Gakkai Zasshi. 2010;107:893-899.
11.
WieseDLashnerBSeidnerD. Measurement of nutrition status in Crohn’s disease patients receiving infliximab therapy. Nutr Clin Pract. 2008;23:551-556.
12.
WaltersTDGilmanARGriffithsAM. Linear growth improves during infliximab therapy in children with chronically active severe Crohn’s disease. Inflamm Bowel Dis. 2007;13:424-430.
13.
DiamantiABassoMSGambararaM. Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn’s disease patients. Int J Colorectal Dis. 2009;24:19-25.
14.
PfefferkornMBurkeGGriffithsA. Growth abnormalities persist in newly diagnosed children with Crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr. 2009;48(2):168-174.
15.
SteinerSJPfefferkornMDFitzgeraldJFDenneSC. Effects of infliximab and parenteral nutrition on albumin and fibrinogen synthesis rates in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2008;47:579-584.
16.
RochaRSantanoGOAlmeidaNLyraAC. Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase. Br J Nutr. 2009;101:676-679.
17.
ValentiniLSchaperLBuningC. Malnutrition and impaired muscle strength in patients with Crohn’s disease and ulcerative colitis in remission. Nutrition. 2008;24:694-702.
18.
BannerjeeKCamacho-HübnerCBabinskaK. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr. 2004;38:270-275.
19.
BreeseEJMichieCANichollsSW. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn’s disease. Aliment Pharmacol Ther. 1995;9:547-552.
20.
GassullMAFernandez-BanaresFCabreE, for the European Group on Enteral Nutrition in Crohn’s Disease. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn’s disease: results of a double blind randomised multicentre European trial. Gut. 2002;51:164-168.
21.
AkobengAKMillerVStantonJElbadriAMThomasAG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn’s disease. J Pediatr Gastroenterol Nutr. 2000;30:78-84.
22.
AnsteeQMForbesA. The safe use of percutaneous gastrostomy for enteral nutrition in patients with Crohn’s disease. Eur J Gastroenterol Hepatol. 2000;12:1089-1093.
23.
Schmidt-WeberCBBlaserK. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol. 2004;16:709-716.
24.
FilippiJAl-JaouniRWirothJBHébuterneXSchneiderSM. Nutritional deficiencies in patients with Crohn’s disease in remission. Inflamm Bowel Dis. 2006;12(3):185-191.
25.
HeuschkelRBMenacheCCMegerianJTBairdAE. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr. 2000;31(1):8-15.
26.
BelliDCSeidmanEBouthillierL. Chronic intermittent elemental diet improves growth failure in children with Crohn’s disease. Gastroenterology. 1988;94:603-610.
27.
LindorKDFlemingCRIlstrupDM. Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn’s disease. Mayo Clin Proc. 1985;60:393-396.
28.
ForbesA. Intestinal failure and short bowel syndrome. Medicine. 2007;35:231-235.
29.
PittirutiMHamiltonHBiffiRMacFieJPertkiewiczM. ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr. 2009;28:365-377.
30.
MehannaHMMoledinaJTravisJ. Refeeding syndrome: what it is, and how to prevent and treat it. Br Med J. 2008;336:1495-1498.
VoitkAJEchaveVFellerJHBrownRAGurdFN. Experience with elemental diet in the treatment of inflammatory bowel disease: is this primary therapy?Arch Surg. 1973;107:329-333.
33.
ZachosMTondeurMGriffithsAM. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2007;(1):CD000542.
34.
EsakiMMatsumotoTHizawaK. Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy. Scand J Gastroenterol. 2005;40:1431-1437.
35.
Fernández-BanaresFCabréEEsteve-ComasMGassullMA. How effective is enteral nutrition in inducing clinical remission in active Crohn’s disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr. 1995;19:356-364.
36.
Compher CW for the ASPEN Board of Directors. Clinical guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients, 2009. JPEN J Parenter Enteral Nutr. 2009;33:255-259.
37.
LochsHDejongCHammarqvistF. ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr. 2006;25:360-374.
38.
TravisSPLStangeEFLémannM, for the European Crohn’s and Colitis Organisation (ECCO). European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. Gut. 2006;55(suppl 1):i16-i35.
39.
MessoriATralloriGD’AlbasioGMillaMVannozziGPaciniF. Defined-formula diets versus steroids in the treatment of active Crohn’s disease: a meta-analysis. Scand J Gastroenterol. 1996;31: 267-272.
40.
GriffithsAMOhlssonAShermanPMSutherlandLR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology. 1995;108:1056-1067.
41.
González-HuixFde LeónRFernández-BañaresF. Polymeric enteral diets as primary treatment of active Crohn’s disease: a prospective steroid controlled trial. Gut. 1993;34:778-782.
42.
AfzalNADaviesSPaintinM. Colonic Crohn’s disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci. 2005;50:1471-1475.
43.
HyamsJS. Risk/benefit strategies must be employed in the management of pediatric Crohn’s disease. Dig Dis. 2009;27:291-296.
44.
BorrelliOCordischiLCirulliM. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol. 2006;4:744-753.
45.
SeidmanEGJonesAIssenmanRGriffithsA. Relapse prevention/growth enhancement in pediatric Crohn’s disease: multi-centre randomized controlled trial of intermittent enteral nutrition versus alternate day prednisone. J Pediatr Gastroenterol Nutr. 1996;23:A344.
46.
HyamsJSFerryGDMandelFS. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
47.
DayASWhittenKELembergDA. Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol. 2006;21:1609-1614.
48.
AfzalNAvan der Zaag-LoonenHJArnaud-BattandierF. Improvement in quality of life of children with acute Crohn’s disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther. 2004;20:167-172.
49.
FellJPaintinMArnaud-BattandierF. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment Pharmacol Ther. 2001;14:281-289.
50.
YamamotoTNakahigashiMSaniabadiAR. Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn’s disease: a prospective study. Inflamm Bowel Dis. 2007;13(12):1493-1501.
51.
WilsonDThomasANewbyE, for BSPGHAN. Systematic review of nutritional therapy for Crohn’s disease in children. J Ped Gastroenterol. 2010 (e-pub).
52.
LudvigssonJFKrantzMBodinLStenhammarLLindquistB. Elemental versus polymeric enteral nutrition in paediatric Crohn’s disease: a multicentre randomized controlled trial. Acta Pædiatrica. 2004;93:327-335.
53.
OckengaJBorchertKStuberELochsHMannsMPBischoffSC. Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur J Clin Nutr. 2005;59:1302-1309.
AkobengAKThomasAG. Enteral nutrition for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2007;(3):CD005984.
56.
TakagiSUtsunomiyaKKuriyamaS. Effectiveness of an “half elemental diet” as maintenance therapy for Crohn’s disease: a randomized-controlled trial. Aliment Pharmacol Ther. 2006;24:1333-1340.
57.
VermaSKirkwoodBBrownSGiafferMH. Oral nutritional supplementation is effective in the maintenance of remission in Crohn’s disease. Dig Liver Dis. 2000;32:769-774.
58.
BelliDCSeidmanEBouthillierL. Chronic intermittent elemental diet improves growth failure in children with Crohn’s disease. Gastroenterology. 1988;94:603-610.
59.
AigesHMarkowitzJRosaJDaumF. Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn’s disease. Gastroenterology. 1989;97:905-910.
60.
MotilKJGrandRJDavis-KraftLFerlicLLSmithEO. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology. 1993;105:681-691.
61.
StewartMDayASOtleyA. Physician attitudes and practices of enteral nutrition as primary treatment of paediatric Crohn disease in North America. J Pediatr Gastroenterol Nutr. 2011;52(1):38-42.
62.
WrightRAAdlerEC. Peripheral parenteral nutrition is no better than enteral nutrition in acute exacerbation of Crohn’s disease: a prospective trial. J Clin Gastroenterol. 1990;12:396-399.
63.
BragaMLjungqvistOSoetersPFearonKWeimannABozzettiF. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr. 2009;28:378-386.
64.
VisschersRGOlde DaminkSWWinkensBSoetersPvan GemertWG. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg. 2008;32:445-453.
65.
EvansJPSteinhartAHCohenZMcLeodRS. Home total parenteral nutrition: an alternative to early surgery for complicated inflammatory bowel disease. J Gastrointest Surg. 2003;7:562-566.
66.
MarkelTALouDCPfefferkornM. Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Surgery. 2008;144:545-547.
67.
McIntyrePBPowell-TuckJWoodSR. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut. 1986;27:481-485.
68.
González-HuixFFernández-BañaresFEsteve-ComasM. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol. 1992;88:227-232.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
